AngioDynamics, Inc. (ANGO) Total liabilities 2017–2026
AngioDynamics, Inc. (ANGO) total liabilities at each fiscal year-end, per SEC filings.
$96.3MFY2026 · since FY2017: $192.9M → $96.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $96.3M | -0.9% |
| FY2025 | $97.2M | -13.3% |
| FY2024 | $112.1M | -27.4% |
| FY2023 | $154.3M | +20.3% |
| FY2022 | $128.3M | +5.1% |
| FY2021 | $122.0M | -12.5% |
| FY2020 | $139.3M | -37.1% |
| FY2019 | $221.6M | +36.1% |
| FY2018 | $162.9M | -15.6% |
| FY2017 | $192.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice